Anti-Cancer Agents in Medicinal Chemistry

(Formerly Current Medicinal Chemistry - Anti-Cancer Agents)


Simone Carradori
Department of Pharmacy
“G. d’Annunzio” University of Chieti-Pescara

Personal Subscription
Become EABM
Become Reviewer

Potential of Selective Estrogen Receptor Modulators as Treatments and Preventives of Breast Cancer

Volume:9   Issue: 5
Pp: 481-499
Jing Peng, Surojeet Sengupta and V. Craig Jordan
DOI: 10.2174/187152009788451833

Actual and Potential Agents and Biomarkers in the Treatment of Cancer

Volume:9   Issue: 5
Pp: 500-516
M. P. Carrera, M. J. Ramirez-Exposito and J. M. Martinez-Martos
DOI: 10.2174/187152009788451824

Role of Oxygen in Cancer: Looking Beyond Hypoxia

Volume:9   Issue: 5
Pp: 517-525
Miguel Lopez-Lazaro
DOI: 10.2174/187152009788451806

The Intermediate Enzymes of Isoprenoid Metabolism as Anticancer Targets

Volume:9   Issue: 5
Pp: 526-542
Andrew J. Wiemer, Raymond J. Hohl and David F. Wiemer
DOI: 10.2174/187152009788451860

Can the Status of the Breast and Ovarian Cancer Susceptibility Gene 1 Product (BRCA1) Predict Response to Taxane-Based Cancer Therapy?

Volume:9   Issue: 5
Pp: 543-549
J. Thomas DeLigio, Aneliya Velkova, Diego A.R. Zorio and Alvaro N.A. Monteiro
DOI: 10.2174/187152009788451798

The PI3K/Akt Pathway as a Target in the Treatment of Hematologic Malignancies

Volume:9   Issue: 5
Pp: 550-559
Kiyotaka Kawauchi, Toshie Ogasawara, Masako Yasuyama, Kuniaki Otsuka and Osamu Yamada
DOI: 10.2174/187152009788451851

Role of Tyrosine Kinase Inhibitors in Lung Cancer

Volume:9   Issue: 5
Pp: 569-575
J. Ansari, D. H. Palmer, D. W. Rea and S. A. Hussain
DOI: 10.2174/187152009788451879

Control of Melanoma Invasiveness by Anticollagenolytic Agents: A Reappraisal of an Old Concept

Volume:9   Issue: 5
Pp: 576-597
Erika Bourguet, Janos Sapi, Herve Emonard and William Hornebeck
DOI: 10.2174/187152009788451842